These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1344303)

  • 21. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
    Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-12-based immunotherapy against rat 9L glioma.
    Jean WC; Spellman SR; Wallenfriedman MA; Hall WA; Low WC
    Neurosurgery; 1998 Apr; 42(4):850-6; discussion 856-7. PubMed ID: 9574650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
    Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
    Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic tumor-specific cytotoxic T lymphocytes.
    Redd JM; Lagarde AC; Kruse CA; Bellgrau D
    Cancer Immunol Immunother; 1992; 34(5):349-54. PubMed ID: 1371720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
    Lefranc F; Cool V; Velu T; Brotchi J; De Witte O
    Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
    Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS
    Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new technique for implanting intracranial 9L tumors in rats.
    Wilkins DE; Raaphorst GP; Saunders JK; Smith IC
    Lab Anim Sci; 1993 Oct; 43(5):518-9. PubMed ID: 8277742
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.
    Kramm CM; Chase M; Herrlinger U; Jacobs A; Pechan PA; Rainov NG; Sena-Esteves M; Aghi M; Barnett FH; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1997 Nov; 8(17):2057-68. PubMed ID: 9414254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
    Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
    Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
    Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
    Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma.
    Olson JJ; Polk DM; Reisner A
    Neurosurgery; 1994 Feb; 34(2):297-308; discussion 308. PubMed ID: 8177391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
    Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
    J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors.
    Liu Y; Wang Q; Kleinschmidt-DeMasters BK; Franzusoff A; Ng KY; Lillehei KO
    J Neurooncol; 2007 Jan; 81(2):149-62. PubMed ID: 16941073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors.
    Manome Y; Wen PY; Hershowitz A; Tanaka T; Rollins BJ; Kufe DW; Fine HA
    Cancer Immunol Immunother; 1995 Oct; 41(4):227-35. PubMed ID: 7489565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy.
    Régnard P; Bräuer-Krisch E; Troprès I; Keyriläinen J; Bravin A; Le Duc G
    Eur J Radiol; 2008 Dec; 68(3 Suppl):S151-5. PubMed ID: 18635331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma.
    Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF
    J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
    Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
    J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.